SCHEMBL23861490

SCHEMBL23861490

CC(C)CC(C)(c1c(O)ccc2ccccc12)c1c(O)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.47
▸ MAPT P10636 4/20 0.47
▸ GAA P10253 4/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HSD17B10 Q99714 3/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PTPN22 Q9Y2R2 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ PAK1 Q13153 1/20 0.40
▸ GLA P06280 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861489 0.83 TYR (0.37) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL23861486 0.81 ESR1 (0.36) ALDH1A1LMNAHSD17B10CYP1A2CYP2C9
SCHEMBL11549229 0.79 HSD17B10 (0.44) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL2221239 0.77 PTPN22 (0.54) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL31356444 0.77 PTPN22 (0.54) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL20398800 0.77 PTPN22 (0.54) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL23499948 0.75 PTPN22 (0.52) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL17722812 0.75 HSD17B10 (0.47) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL8388759 0.74 PTPN22 (0.50) KDM4EMAPTGAAALDH1A1KMT2A
SCHEMBL5596944 0.74 PTPN22 (0.50) KDM4EMAPTGAAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 KDM4E 822/4885MAPT 3949/4885GAA 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback